Saxitoxin and neosaxitoxin are potent neurotoxins that can cause paralytic shellfish poisoning when consumed. A new assay is presented here to quantify saxitoxin (STX) and neosaxitoxin (NEO) in human urine samples. Sample preparation of 500-µL samples included the use of weak-cation-exchange solid-phase extraction in a multiplexed 96-well format. Extracts were preconcentrated and analyzed via 10-min hydrophilic interaction liquid chromatography followed by electrospray ionization. Protonated molecular ions were quantified via multiple reaction monitoring mode in a Qtrap mass spectrometer. The method uses novel 15 N 7 -isotopically enriched STX and NEO internal standards. Method validation included the characterization of two enriched urine pools. The lowest reportable limits for STX and NEO were 4.80 and 10.1 ng/mL, respectively, using both quantification and confirmation ions. These two toxins were not detected in a reference range of humans who consumed seafood in the preceding 72 h, suggesting that few false positives would occur when trying to identify people exposed to STX or NEO.
Introduction
Saxitoxin (STX) is one of the most potent marine toxins (1) and is restricted as an Organization for the Prohibition of Chemical Weapons (OPCW) Schedule 1 chemical agent (2) . Neosaxitoxin (NEO) is one of numerous derivatives of STX in a class of compounds known as saxitoxins (Figure 1 ) or paralytic shellfish poisoning (PSP) toxins (1) . Public health officials are concerned about these toxins because they are naturally occurring seafood contaminants, found commonly in shellfish or their predators (3, 4) . There are numerous PSP toxin variants, including 1. carbamates; 2. decarbamoyl-derivatives; and 3. N-sulfocarbamoyl-derivatives (5) . Carbamates are the most toxic group of paralytic shellfish poisoning toxins and include STX, NEO and gonyautoxins I-IV. PSP toxins are produced by various dinoflagellates (5, 6) and cyanobacteria (7) that may or may not produce colorful algal blooms known as Red Tides (3) .
PSP toxin exposure can produce a spectrum of symptoms ranging from mild to life-threatening. Symptoms described have included perioral and limb paresthesias, nausea, muscle weakness, and paralysis. Death, when it occurs, is usually a consequence of respiratory paralysis (4, 8) . Binding of PSP toxins to the sodium channels in nerve and muscle cell membranes is reversible (9) , and the effects are usually transient (10) (11) (12) (13) . Supportive care is the primary treatment for PSP victims and patients improve significantly within 24 h post-exposure (8, 14) . Numerous human cases (8, 14, 15) and animal metabolism studies (6, 16, 17) describing the action of PSP toxins have been reported. Rapid saxitoxin clearance is predominantly via glomerular filtration with no metabolism or excretion in the feces (16, 18) . From the limited data available, the half-life of saxitoxin in humans appears to be less than 10 h (15) . The mouse LD 50 is calculated to be 2.4 µg/kg (i.v.), 10 µg/kg (i.p.), and 263 µg/kg (oral) (3, 19) .
The traditional method for the detection of saxitoxin in shellfish is the mouse bioassay (20) , which determines total toxicity in a sample. However, the animal bioassay has several disadvantages, including the use of live animals, the lack of PSP toxin specificity, and a limit of detection of about 50% of the regulatory limit of PSP in food (80 µg/100 g in shellfish). Other methods have been developed which focus on affinitybinding or the molecular structure of PSP toxins. These assays include radio-receptor assays (21, 22) , enzyme-linked immunoassays (23) (24) (25) , and liquid chromatography (LC) coupled to fluorescence detection (16, 26, 27) . Binding assays rely on either animal-dependent extracts, which can include sodium channels or antibodies bound to a substrate. The selectivity of each assay is based on the property of the PSP toxin that is exploited for binding. LC has been used to differentiate the various PSP toxins, and fluorescence detection has been based on the aromatic end product of PSP oxidation under alkaline conditions. Mass spectrometry (MS) is the only method that offers the ability to directly examine the molecular structure of PSP toxins and can differentiate the individual species when coupled together with LC (28) (29) (30) .
The MS method presented here is designed to analyze human urine samples for STX or NEO. It is the first reported use of an isotopically enriched saxitoxin or neosaxitoxin internal standard that compensates for variations in extraction, chromatography, or detector response. In addition, it utilizes weak cation exchange extraction in an efficient 96-well sample format designed to be used with a high-throughput liquidhandling robot. The net result is a method with no observed interferences from the urinary matrix and the ability to process large numbers of human urine samples quickly and reliably.
Experimental Chemicals
High-performance liquid chromatograpy (HPLC)-grade methanol, acetonitrile and deionized water were purchased from Tedia (Fairfield, OH). Ammonium formate and formic acid were purchased from Sigma Chemical (St. Louis, MO). Phosphate buffer (pH 6.4) was purchased from LabChem (Pittsburgh, PA). The phosphate buffer contained 0.66% potassium dihydrogen phosphate (CAS 7778-77-0), 0.32% disodium hydrogren phosphate (CAS 7558-79-4), and 0.1% formaldehyde (CAS 50-00-0) in water. As used in this method, the phosphate buffer was diluted to 40% in deionized water; the dilute form was referred to as dilute phosphate buffer. Pooled urine was collected from anonymous donors in urine specimen cups, homogenized (magnetic stirrer) for 12 h in a brown bottle, and then stored at -20°C until needed. Certified native STX and NEO calibration material for method development and validation were purchased from the Canadian National Research Council (Halifax, NS, Canada). Isotopically labeled 15 N 7 -STX and 15 N 7 -NEO internal standards, at concentrations of 1 mg/mL, were obtained from the U.S. Food and Drug Administration (College Park, MD). These were packaged and are maintained at CDC as an inventory to support the Laboratory Response Network (LRN).
Preparation method
A STX and NEO stock solution was prepared by mixing 10 µL of the certified native STX and native NEO with 980 µL of urine. Calibrators were prepared fresh daily using serial dilution from the working stock solution to concentrations of 145.2, 121, 48.4, 9.7, and 4.8 ng/mL STX and 151.2, 126, 50.4, 10.1, and 5.0 ng/mL NEO. Quality control (QC) materials were produced daily by dilution of stock standards into urine to generate different concentrations of 96.8 and 14.5 ng/mL STX and 100.8 and 15.1 ng/mL NEO. Blank solutions contained the urine pool used for serial dilutions without any further enrichment with STX and NEO. The final volume of all solutions was 500 µL. 25 µL of internal standard was spiked into each standard, QC material and unknown. Only a 400-µL aliquot of the 525 µL prepared sample was transferred to another 2000-µL well plate, and diluted with 800 µL of dilute phosphate buffer prior to extraction.
A Tomtec Quadra 3 (Hamden, CT) liquid handler was equipped with a solid-phase extraction (SPE) vacuum manifold, two tip stations (for clean and used tips) and a combination of three other stations which contained either solution and solvent reservoirs or sample plates. The extraction procedure utilized United Chemical Technologies (UCT, Bristol, PA) 96-well extraction plates (Part No. WORCCX11 carboxylic acid, 100 mg sorbent bed). The plate was conditioned using 1125 µL each of methanol, water, and dilute phosphate buffer. Sample (1125 µL) was transferred to the SPE plate and vacuum (10-25 bar) was applied to slowly draw sample through to a waste receiving reservoir. Unused wells were capped with a square silicone mat (Millipore, Bedford, MA) to improve sample and solvent loading. The two rinse steps consisted of 750 µL of water, followed by 1125 µL of acetonitrile. A 2000-µL Nunc round-bottom (Rochester, NY) sample receiving plate was then inserted into the extraction manifold, and the analytes were eluted using 1125 µL of 5% formic acid in methanol solution.
Samples were dried at 45°C using a TurboVap 96 (Hopkington, MA) and a nitrogen flow ranging from 20 to 50 standard cubic feet per h (SCFH) divided among all 96 nitrogen nozzles. A flow rate of 20 SCFH for 15 min was followed by a flow rate of 50 SCFH for 30 min to dry the plates. It proved helpful to label a "low flow" and "high flow" side of the TurboVap 96 to prevent adding a full sample plate to the high flow side and cause splashing. It was also useful to use the deep-well receiving plate that was about twice the elution volume, likewise reducing the chance of splashing when drying down the sample.
The dried sample was reconstituted with 100 µL of 75% acetonitrile/25% methanol solution and mixed for 5 min on an orbital plate shaker (Thermo Wellmix, Germany). The sample was transferred to a 96-well plate filter (Millipore, Bedford, MA) using a microtiter plate (Advion, Ithaca, NY) for receiving. The sample was centrifuged for 10 min at a speed of 2000 RPM. The Advion PCR plate was then sealed using 20-µm foil and foil sealer (Ithaca, NY).
Apparatus
Extracted samples were injected into the MS using an Agilent 1100 capillary HPLC equipped with a degasser, a well plate autosampler, and a column heating compartment. An Atlantis hydrophilic interaction chromatography (HILIC) silica 2-µm column (1.0 × 50-mm, Waters, Milford, MA) was operated isocratically at 40°C. The mobile phase consisted of 375 mL acetonitrile, 100 mL deionized water, 25 mL methanol with 474 mg ammonium formate, and 510 µL formic acid. The injection volume was 20 µL.
An Applied Biosystems API 4000 Qtrap MS (Foster City, CA) was operated in positive ion mode using a turbo ion spray source operated at 250°C. The analytes were analyzed via the following instrument settings: 300 ms per selected reaction monitoring channel, collisionally activated dissociation (CAD) set to 4, CAD gas set to 15, source gas 1 set to 20, source gas 2 set to 40, and the ion spray voltage set to 5500 volts. The settings for the declustering potential, entrance potential, and collision cell exit potential were 51, 10, and 16, respectively. Collision energies were optimized per analyte multiple reaction monitoring (MRM) conditions and are summarized in Table I . Nitrogen was used as the collison gas.
Data analysis
Data analysis was performed using the Analyst 1.4.2 instrument software. A 1/x-weighted linear least-squares regression was applied to the standard concentration versus the ratio of the quantification ion area to the internal standard area. A separate calibration curve was also generated using the standard concentration versus the ratio of the confirmation ion to internal standard area. The response for both curves was linear over the entire range of standards with a correlation coefficient of 0.985 or greater. For a positive result to be accepted, the calculated concentration must match within 10% using both calibration curves.
The area ratio of the quantitative ion to the confirmation ion, referred to as the confirmation ratio, was also used to confirm positive results when within 20% of the batch mean confirmation ion ratio. An analytical batch consisted of a blank, calibrators, quality control materials and unknowns (reference range samples), and only the calibrators were used when calculating the batch mean confirmation ratio. No positive interferences were observed in the current work.
Statistical limits for the quality control materials were established from the results of 19 characterization experiments (analytical batches) using SAS software. 95% confidence limits were used to evaluate the quality control materials used when quantifying the reference range samples. The method precision and accuracy from 19 analytical batches analyzed over 1 year was determined using an in-house laboratory information management system (LIMS). The coefficient of variance for each quality control material is reported in Table II , as well as the accuracy of the method, based on the expected concentrations of each. The LIMS system likewise calculated the method limit of detection (LOD) based on the Taylor calculation (31), which plots the absolute standard deviation of the lowest four calibrators, with respect to concentration. The y-intercept, s o , is multiplied by 3 to determine the method LOD.
Relative recovery experiments
Relative recovery experiments were performed to evaluate the analyte recovered from the extraction process. The experiments included a total of four samples, two prepared as described in Preparation method, and two samples in which the internal standard was added after the extraction but prior to the dry-down step. The ratio of the native analytes and internal standards was used to calculate the percent relative recovery.
Reference range of samples
Anonymous urine samples were collected from 72 donors who had consumed seafood in the previous 3 days. No other information was available from these donors, such as any per- 
Results and Discussion
We developed a precise and accurate isotope-dilution MS (IDMS) method for quantifying urinary concentrations of STX and NEO in an efficient high-throughput format. 15 N 7 -Enriched STX and NEO were used to characterize an IDMS method which was based on a 96-well carboxylic acid resin extraction, hydrophilic interaction chromatography (HILIC), and positive ion MRM MS. The combined method was evaluated for precision and accuracy, LODs and stability using spiked urine samples. Urine from individuals who reported having consumed seafood were evaluated to determine an expected reference range of urinary concentrations.
Sample preparation
Weak cation exchange is well suited for STX and NEO preparation due to the cationic nature of the analytes(1). In order to condition the sorbent bed, it was most efficient to use methanol, followed by water and then dilute phosphate buffer at pH 6.4. At this pH and low ionic strength, STX and NEO are in a cationic state. A minimal aqueous rinse was used to eliminate urinary salts without changing the buffering pH of the sorbent bed. Then a 100% organic rinse removed residual hydrophobic compounds. The compounds were eluted in 5% formic acid in methanol.
Relative recovery measurements were used to evaluate the extraction step. In these experiments, the internal standard was either added to the urine sample before the extraction (normaladdition) or after (post-addition). This involved a total of five experiments: analysis of a negative control (blank), two normal-addition experiments, and two post-addition experiments. The ratios of the native to labeled analytes were recorded for each experiment. The average post-addition experiment ratio was divided by the average normal-addition experiment ratio to produce the relative recovery ratio. This was multiplied by 100% and yielded a percent relative recovery of 90% for both STX and NEO. It should be noted that this method uses internal standards that are isotopically labeled and therefore behave chemically in a similar manner to the unlabeled compounds but can be distinguished by their masses. Thus, the use of these isotopically labeled internal standards corrects for recovery, any minor variations in chromatography, and for matrix effects in the electrospray ionization source; the percent recovery of the method will only influence the method sensitivity and not the accuracy.
Chromatography and MS
The HILIC separation utilized a bare-silica column that removed variances from derivatives of the stationary phase but also increased ion-exchange between the analyte and the stationary phase. As in the case of the sample preparation, hydrophobic stationary phases were not suitable due to the high polarity of the analytes, and deprotonation of STX and NEO was not feasible because of their vulnerability to oxidation at high pH. HILIC relies on the partitioning of analytes between a trapped water layer at the stationary phase surface and the hydrophobic properties of the mobile phase. The presence of any residual water in the sample appeared to degrade the chromatographic resolution of the STX and NEO and necessitated the use of a high concentration of methanol in the reconstitution solvent to dissolve the analytes.
STX and NEO interacted strongly with the HILIC column silica stationary phase. To reduce this ion-exchange interaction, a high buffer strength was used, which decreased the peak width of the chromatographic peak from 1.5 to 0.5 min and reduced each analyte retention time from 5 to about 3.7 min. Typical retention times were 3.9 min for STX and 3.6 min for NEO. Clogging of the HPLC injector and capillary tubing was a concern because of the combined use of a high buffer concentration and restricted capillary tubing. A 60-min post-analytical batch rinse of the HPLC, using 50% methanol/50% acetonitrile, reduced this maintenance issue.
Effluent from the HILIC separation was ionized via positive electrospray at a reduced temperature (250°C) because of the high organic concentration of the mobile phase. The lower temperature also reduced the possibility of thermal degradation of the toxins. Interestingly, a doubly charged molecular ion was not observed, as might be expected. Quantification was performed via MRM, where the quantification and confirmation ions were selected as the most abundant ions from the analyte product ion mass spectra (Table I, Figures 2 and 3 ). The gas phase disassociative behavior of protonated saxitoxin and neosaxitoxin has previously been explained in detail using high-resolution MS (32) . In the case of saxitoxin, the product ion used for MRM quantification (m/z 204[C 9 H 10 N 5 O + ], derived from m/z 300[M+H] + ) has been reported to result from the initial loss of ammonia at carbon-8 (Figure 1) , followed by the loss of OCNH at oxygen-18, loss of water at carbon-12 and the loss of water from the carbon-17 atom. The initial loss of water from either saxitoxin or neosaxitoxin was reported to be derived from the carbon-12 hydrated ketone. The loss of water from the hydrated ketone served as the confirmation ion for saxitoxin, but it was used as the quantification ion for neosaxitoxin because of its higher intensity (32) . The neosaxitoxin confirmation ion (m/z 220[C 9 H 10 N 5 O 2 + ], derived from (m/z 316[M+H] + ) was previously reported to result from the sequential loss of water at carbon-12, ammonia at carbon-8, water at nitrogen-1, and isocyanate at oxygen-18 (32).
Method evaluation
The method LOD was calculated by plotting the absolute standard deviation of the relative response factor of the lowest four standards of each analyte and performing a least-squares regression to determine the y-intercept, s o (31) . The product of s o multiplied by 3 is the method LOD and was calculated to be below the lowest calibrator used (4.80 ng/mL for saxitoxin and 10.1 ng/mL for neosaxitoxin) using both a quantification and confirmation ion. This LOD correlated to 333 pg of STX and 700 pg of NEO injected on-column. Figure 4 shows an MRM chromatogram at each analytes lowest reportable limit (LRL), which are above their respective LODs. Below these respective concentrations, the confirmation ion was not consistently present and could not be used to eliminate positive interferences. Therefore, the lowest calibrator with a consistent confirmation ratio was reported as the lowest reportable limit. The limitation of the method sensitivity was due to the high degree of fragmentation of the molecule when using multiple reaction monitoring.
The isotopically enriched internal standards disassociated in a manner consistent with the native analytes, and their mass spectra did not contain any interferences to or from the native compound. As a result, the internal standards were used without requiring cross-correction of the areas of the quantification and reference peaks. The internal standards were also found to be stable at 5°C for up to 1 year in dilute aqueous solution, 1 µg/mL. Concentrated stocks of the internal standard, 1 mg/mL, were likewise stable when stored at -70°C for 1 year, at a pH of 4.
The quality control (QC) materials consisted of three urine pools: a blank (unenriched urine pool), a low-QC pool enriched at a concentration of 14.5 ng/mL for STX and 15.1 ng/mL for NEO, and a high-QC pool enriched at 96.8 ng/mL for STX and 100.8 ng/mL for NEO. The quality control materials were characterized for mean and coefficient of variation using 19 batches over a 1-year period. The percent coefficient of variation (CV) for the low-QC was 6.08% for STX and 8.53% for NEO, and the CV for the high-QC was 4.46% for STX and 6.13% for NEO. The mean accuracy for the method was greater than 93% for both saxitoxin and neosaxitoxin in the low-QC pool and was 98% for both analytes in the high-QC pools. Characteristics of the quality control pools given in Table II show that the method produces results that are highly precise and accurate for an ultra-trace method (31) .
STX and NEO from seafood eaters and reported levels from toxic exposures
STX and NEO are naturally occurring toxins and low levels could be present in human urines collected from individuals with low level exposures. To investigate possible endogenous interferences and to characterize toxin levels in individuals that eat seafood, random specimens from seafood eaters were analyzed to insure a low rate of false-positive results. This information is crucial to make public health decisions in the event of a poisoning involving STX or NEO.
Urine samples from 72 individuals were collected anonymously from people who indicated they had consumed unspecified seafood in the previous 3 days. No other information, including identity of the donor, age, race, gender, or quantity or time since the consumption of seafood, was gathered. No interferences or positive results were detected in the analysis of these limited reference range samples.
The effectiveness of this method for clinical assay depends on the original quantity and distribution of PSP toxins in the food which was consumed. Llewellyn et al. (14) reported saxitoxin equivalents in postmortem urine samples at 121 ng/mL or more (12.1 µg STXeq/100 mL urine) containing about 50% saxitoxin, 10% neosaxitoxin, and 40% decarbamoyl-saxitoxin (dcSTX). In a postmortem case, Garcia et al. (8) reported a urinary concentration of 1800 ng/mL, which is many times greater than the highest calibrator reported here, and would require dilutions for quantification. In either example, STX or NEO at these concentrations would be readily quantifiable by the method described in this report.
MS is an inherently sensitive analytical technique that is used widely to measure extremely low levels of analytes of interest. The use of tandem MS and a confirmation ratio ensure that the method is selective and rule out possible interferences that may derive from other endogenous sources. The use of labeled internal standards expands on the sensitivity and selectivity of mass spectrometry by compensating for any variation which occurs in extraction efficiencies. The results from analyzing samples obtained from individuals who had recently consumed seafood indicated that endogenous compounds from diet and lifestyle do not interefere with this analytical results obtained using this method. The reference range also indicated that further improvements in the method LOD will be necessary to detect low-level exposures to marine toxins which do not produce an adverse health effect.
Although this method only utilizes two parent toxins, the approach can be compared to several existing methodologies for PSP toxin assay. The primary difference between this method and others for analyzing STX is that it has been developed for human urine samples only, whereas most other methods focus on seafood analysis. This requires a different approach to the problem because of sensitivity requirements but provides a retrospective approach to a poisoning event; a contaminated seafood source may have been completely consumed or may no longer be available.
In comparison to other methodologies, the IDMS method offers features which make it a more effective means of analyzing STX and NEO in urine. The LODs for the IDMS method are comparable to the liquid chromatography fluorescence based assay and the HILIC tandem MS method used to analyze seafood. However, the use of the isotopically labeled internal standard compensates for variances in extraction efficiency, chromatography, and increases method accuracy and precision. With respect to the ELISA methodologies, the IDMS method provides greater selectivity through mass differentiation of components of the sample which is not possible in ELISA. The IDMS method provides many of the time-saving and improved sample throughput features that result from an efficient 96-well format but requires a higher initial capital investment. In comparison to the mouse bioassay and radiobinding assay, the IDMS method cannot determine total toxicity of samples. As with any selective assay including IDMS, fluorescence, or ELISA, any unexpected toxin will not be detected. In response to this limitation, future method development will focus on providing more generic MS-based assays that can provide quantitative data on categories of toxins.
Conclusions
This research presents a new methodology specifically designed for quantifying human urinary concentrations of saxitoxin and neosaxitoxin using IDMS. Advantages of this method include the sensitivity, selectivity, and accuracy of ID tandem MS and the ability to simultaneously prepare 96 samples. The use of an isotopically labeled internal standard compensates for variances in extraction efficiency and chromatographic separation. The LRLs for this method are 4.80 ng/mL and 10.1 ng/mL for STX and NEO, respectively. These levels are adequate for quantifying exposure to PSP toxins according to previously reported concentrations of the analytes from suspected exposures. This method will be useful in quantifying human exposure to STX and NEO to assist in patient treatment and differentiate PSP toxin exposure from exposure to other toxins which may present with similar symptoms. Future research directions of this method include decreasing the LODs in order to access low level exposure to PSP toxins and creating more generic MS-based scans. Decreasing the LOD would allow for more accurately assessing exposure to marine toxins from routine consumption of seafood which does not produce a detrimental physiological response. The development of a generic assay will allow for the determination of unexpected PSP toxin variants that may be present in the seafood or as metabolites in the body.
